We identified the crucial role that AQP4 plays in the immune microenvironment of malignant gliomas, suggesting that AQP4 has the potential to be a breakpoint in malignant glioma for future discovery of the immune microenvironment of glioma. The gene discussed is AQP4; the disease is central nervous system cancer.